T0	Interventions 129 141	chemotherapy
T1	Interventions 524 686	various analytic methods to evaluate the probability of response and identify independent predictors of progression-free survival (PFS) and overall survival (OS).
T2	Interventions 695 707	Single agent
T3	Interventions 711 744	combination chemotherapy regimens
T4	Interventions 755 770	doxorubicin (A)
T5	Interventions 778 799	doxorubicin/cisplatin
T6	Interventions 812 834	doxorubicin/paclitaxel
T7	Interventions 851 883	paclitaxel/doxorubicin/cisplatin